Loading…
Loading…
Paragon Care (ASX:PGC), a healthcare distribution group, divides fund managers over its balance sheet and acquisition strategy. In June 2026, Wilson Asset Management explained it exited in December 2025 after disappointing results and a run of acquisitions that strained the balance sheet, rating it a hold. Forager Funds rated Paragon a buy, describing it as a value play it has recently added, and First Samuel argued the core business delivered a respectable half beneath messy statutory numbers. Paragon Care operates in the Healthcare sector within the Healthcare Providers and Services industry, and Thesis Tracker has captured 10 comments from 5 fund managers, including Wilson Asset Management, Forager, First Samuel and Tamim. Founded in 1994 and headquartered in Mount Waverley, Melbourne, Paragon Care distributes medical devices, diagnostic and scientific products, pharmaceuticals and consumables to hospitals, aged care and pharmacies across Australia, New Zealand and Asia.
Company figures as of 15 Oct 2026. For information only.
Fund managers including Endeavor Asset Management, Forager Funds, Wilson Asset Management, Tamim Funds Management and First Samuel have invested in Paragon Care Ltd (ASX:PGC).
Forager sees a value opportunity after the share price fall, and First Samuel believes the core business performed respectably once one-off items are excluded. Tamim highlights expansion through the Somnotec acquisition, extending medical device distribution into Southeast Asia.
Wilson Asset Management exited due to excessive leverage after a series of acquisitions and disappointing results, and highlighted issues in parts of the business. First Samuel acknowledged statutory results looked poor, making the stock easy for the market to dismiss.
Paragon Care Ltd., headquartered in Mt. Waverley, Australia, supplies medical equipment to the health and aged care sectors since 1994. Its business is structured into four primary segments. Diagnostic and Scientific provides blood bank, clinical pathology, and laboratory equipment. Devices focuses on ophthalmology, orthopedics, pain management, infection prevention, and OrthoBiologics. Capital and Consumables delivers medical, surgical, and veterinary products. Service and Technology offers medical device support, capital equipment management, and service partnerships.
General information only. Thesis Tracker reports what named fund managers have published about ASX companies. It does not take into account your objectives, financial situation or needs, and is not financial product advice or a recommendation to buy, sell or hold any security.
11,356 comments from 164 managers on 761 companies, snapshot 15 Oct 2026.